Optimizing Pain Control After Transurethral Resection of the Prostate by Comparing Multi-Modal Pain Management to Standard Care

What this Trial Is About

Researchers are evaluating a new approach to managing pain after transurethral resection of the prostate (TURP) that aims to reduce opioid use. The study compares a multi-modal pain control protocol, which combines two or more pain relief agents acting by different mechanisms, to the current standard care that primarily uses opioids. The goal is to provide similar pain relief while minimizing opioid use, addressing concerns related to the opioid epidemic in surgical patients. Participants are randomly assigned to one of two groups. The standard care group receives medications including topical lidocaine gel, acetaminophen, oxycodone, and other supportive drugs both during hospitalization and after discharge. The multi-modal group receives a regimen that adds ibuprofen and patient education about pain and opioid use, aiming to reduce opioid consumption. Both groups get similar supportive medications for urinary symptoms and constipation. The study period includes inpatient treatment and discharge medication prescriptions. During the study, participants' opioid use and pain levels are monitored from post-anesthesia care through 72 hours after surgery. Researchers also track the presence of urinary catheters at discharge, side effects from narcotics within 48 hours after discharge, and any post-operative complications. Participants are evaluated through medication usage records and pain scores to assess the effectiveness of the pain management protocols, ensuring careful monitoring of safety and outcomes throughout the study.

Optimizing Pain Control in Transurethral Resection of the Prostate